Welcome to the MNI induced pluripotent stem cell (iPSC)/CRISPR Platform. Dr. Durcan talks about the iPSC Platform in this video.

Established in 2015 with thanks to a private donation and funding from Brain Canada, the Montreal Neurological Institute (MNI) and the Quebec Parkinson’s Network; the MNI iPSC/CRISPR platform is part of a provincial partnership with the iPSC reprogramming platform at the Université of Laval. With expertise in neuronal differentiation and CRISPR genome editing, the platform strives to work with academic and industry users. As part of our services, we can:

  • Provide neuronal progenitors and different neurons from our “In house” catalog of iPSC cell-lines or from user-provided cell-lines.
  • Work with users in the design and execution of assays using iPSC-derived neurons.
  • Train users “in house” on the generation of neurons from iPSCs, making all platform protocols openly available to all users as part of the MNI Open-Science initiative.

If interested in working with iPSCs for your research, feel free to contact thomas.durcan [at] mcgill.ca (Thomas Durcan) or lenore.beitel [at] mcgill.ca (Lenore Beitel) for any further information or to set up an initial meeting.